Postantibiotic and post-beta-lactamase inhibitor effect of carbapenems combined with EDTA against Pseudomonas aeruginosa strains producing VIM-metallo beta-lactamases

Chemotherapy

Volumn 54, Issue 3, 2008, Pages 188-193

  Bedenic B ^a,c   Vranes J ^a   Sviben, M ^b   Beader, N ^a   Kalenic S ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b CROATIAN NATIONAL INSTITUTE OF PUBLIC HEALTH   (Croatia)

^c KBC Zagreb   (Croatia)

Author keywords

EDTA; Imipenem; Meropenem; Post beta lactamase inhibitor effect; Postantibiotic effect

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAMASE INHIBITOR; EDETIC ACID; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; METALLO BETA LACTAMASE VIM 1; METALLO BETA LACTAMASE VIM 2;

ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; CONCENTRATION RESPONSE; ENZYME INHIBITION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CARBAPENEMS; EDETIC ACID; ENZYME INHIBITORS; MICROBIAL VIABILITY; PSEUDOMONAS AERUGINOSA; TIME FACTORS;

EID: 46449132577     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000140461     Document Type: Article

References (17)

1. Bradford PA: Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001;14:933-951.
2. Hanberger H, Lennart EN, Kihlstrom E, Maller R: Postantibiotic effect of β-lactam antibiotics of Escherichia coli evaluated by bioluminescence assay of bacterial ATP. Antimicrob Agents Chemother 1990;34:102-106.
3. Lavigne JP, Bonnet R, Charachon SM, Jourdan J, Caillon J, Sotto A: Post-antibiotic and post-β-lactamase inhibitor effects of ceftazidime plus sulbactam on extended-spectrum β-lactamase producing Gram-negative bacteria. J Antimicrob Chemother 2004;53:616-619.
4. Thornburn CE, Molesworth SJ, Sutherland R, Rittenhouse S: Postantibiotic and post- β-lactamase inhibitor effect of amoxicillin plus clavulanate. Antimicrob Agents Chemother 1996;40:2796-2801.
5. Murbach V, Dhoyen N, Kinger H, Jehl F: Evidence for a true post- β-lactamase-inhibitor effect of clavulanic acid against Klebsiella pneumoniae and Haemophilus influenzae. Clin Microbiol Infect 2001;7:661-665.
6. Giamarellos-Bourboulis EJ, Kentepozidis N, Antonopoulou A, Plachouras D, Tsaganos T, Giamarellou H: Postantibiotic effect of antimicrobial combinations on multidrug-resistant Pseudomonas aeruginosa. Diagn Microbiol Infect Dis 2005;51:113-117.
7. Boswell FJ, Andrews JM, Wise R: Postantibiotic effect of trovefloxacin on Pseudomonas aeruginosa. J Antimicrob Chemother 1997;39:811-814.
8. Bustamante CI, Drusano GL, Tatem BA, Standford HC: Postantibiotic effect of imipenem on Pseudomonas aeruginosa. Antimicrob Agents Chemother 1984;36:678-682.
9. Ferrara A, Santos C, Cibro M: Postantibiotic effect of meropenem in combination with gentamicin or sparfloxacin on Gram-positive and Gram-negative organisms. Clin Microbiol Infect 1998;4:431-434.
10. Nordmann P, Poirel L: Emerging carbapenemases in Gram-negative aerobes. Clin Microbiol Infect 2002;8:321-331.
11. Bonfiglio G, Marcheti F: In vitro activity of ceftazidime, cefepime and imipenem on 1,005 Pseudomonas aeruginosa clinical isolates either susceptible or resistant to β-lactams. Chemotherapy 2000;46:229-234.
12. Walsh F, Bracher S, Turner P, Amyes S: Preferential selection of IMP and VIM metallo- β-lactamases by imipenem in Pseudomonas aeruginosa. Chemotherapy 2007;53:407-409.
13. Lee K, Lim YS, Yong D, Yum JH, Chong Y: Evaluation of the Hodge test and the imipenem-EDTA test and the imipenem-EDTA double-disk synergy test for differentiating metallo- β-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol 2003;41:4623-4629.
14. National Committee for Clinical Laboratory Standards: Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, ed 5. Approved standard M7-A5. Wayne, NCCLS, 2000.
15. Docquier JD, Brasseur JL, Galleni M, Amicsante G: On functional and structural heterogeneity of VIM-type metallo-β-lactamases. J Antimicrob Chemother 2003;51.257-266.
16. Migliavacca R, Docquier JD, Mugnaioli C, Amicosante G, Daturi R, Lee K, Rossolini GM, Pagani L: Simple microdilution test for detection of metallo β-lactamase production in Pseudomonas aeruginosa. J Clin Microbiol 2002;40:4388-4390.
17. Wiseman LR, Wagstaff AJ, Brogden RN, Bryson HM: Meropenem: a review of its antibacterial activity, pharmacokinetic properties and clinical efficacy. Drugs 1995;50:73-101.